|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | A61K 9/70 | |
| A61K 47/30 |
| (11) | Number of the document | 2688561 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12759891.0 |
| Date of filing the European patent application | 2012-03-22 | |
| (97) | Date of publication of the European application | 2014-01-29 |
| (45) | Date of publication and mention of the grant of the patent | 2018-08-22 |
| (46) | Date of publication of the claims translation |
| (86) | Number | PCT/US2012/030171 |
| Date | 2012-03-22 |
| (87) | Number | WO 2012/129429 |
| Date | 2012-09-27 |
| (30) | Number | Date | Country code |
| 201161467337 P | 2011-03-24 | US |
| (72) |
HAMLIN, Richard, US
WEN, Jianye, US
|
| (73) |
Teikoku Pharma USA, Inc.,
1718 Ringwood Avenue, San Jose, CA 95131,
US
|
| (54) | TRANSDERMAL COMPOSITIONS COMPRISING AN ACTIVE AGENT LAYER AND AN ACTIVE AGENT CONVERSION LAYER |
| TRANSDERMAL COMPOSITIONS COMPRISING AN ACTIVE AGENT LAYER AND AN ACTIVE AGENT CONVERSION LAYER |